Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat

Journal of Neuroscience Research

Volumn 52, Issue 3, 1998, Pages 342-349

  Zhang, Chen ^a   Raghupathi, Ramesh ^a   Saatman, Kathryn E ^a   Smith, Douglas H ^a   Stutzmann, Jean Marie ^b   Wahl, Florence ^b   McIntosh, Tracy K ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Neurodeg Dis Psychopharmacology D   (France)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Excitotoxicity; Fluid percussion; Glutamate antagonist; Lesion volume; Neuroprotection

Indexed keywords

RILUZOLE; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN INJURY; DRUG EFFECT; HIPPOCAMPUS; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032080444     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8     Document Type: Article

References (65)

1. Benavides J, Camelin JC, Mitrani N, Flamand F, Uzan A, Legrand J-J, Gueremy C, Le Fur G (1985): 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission - II Biochemical properties. Neuropharmacology 24:1085-1092.
2. Benazzouz A, Boraud T, Dubedat P, Boireau A, Stutzmann J-M, Gross C (1995): Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. Eur J Pharmacol 284:299-307.
3. + channels in myelinated nerve fibre. Pflügers Archive 419:603-609.
4. Bensimon G, Lacomblez L, Meininger V, ALS/Riluzole Study Group (1994): A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585-591.
5. Boireau A, Miquet JM, Dubedat P, Meunier M, Doble A (1994): Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo. NeuroReport 5:2157-2160.
6. Bramlett HM, Dietrich WD, Green EJ, Busto R (1997): Chronic histopathological consequences of fluid-percussion brain injury in rats: effects of post-traumatic hypothermia. Acta Neuropathol 93:190-199.
7. Bramlett HM, Green EJ, Dietrich WD, Busto R, Globus MYT, Ginsberg MD (1995): Posttraumatic brain hypothermia provides protection from sensorimotor and cognitive behavioral deficits. J Neurotrauma 12:289-298.
8. Colicos MA, Dixon CE, Dash PK (1996): Delayed, selective neuronal death following experimental cortical impact injury in rats: possible role in memory deficits. Brain Res 739:111-119.
9. Cortez SC, McIntosh TK, Noble L (1989): Experimental fluid percussion brain injury: Vascular disruption and neuronal and glial alterations. Brain Res 482:271-282.
10. Dietrich DW, Alonso O, Busto R, Finklestein SP (1996): Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats. J Neurotrauma 13:309-316.
11. Dietrich WD, Alonso O, Busto R, Globus MY, Ginsberg MD (1994a): Posttraumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol 87:250-258.
12. Dietrich WD, Alonso O, Halley M (1994b): Early microvascular and neuronal consequences of traumatic brain injury: A light and electron microscopic study in rats. J Neurotrauma 11:289-301.
13. Doble A (1996): The pharmacology and mechanism of action of riluzole. Neurology 47:S233-S241.
14. Estevez AG, Stutzmann J-M, Barbeito L (1995): Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur J Pharmacol 280:47-53.
15. Faden AI, Demediuk P, Panter SS, Vink R (1989): The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:789-800.
16. Globus MYT, Alonso O, Dietrich WD, Busto R, Ginsberg MD (1995): Glutamate release and free radical production following brain injury: Effects of posttraumatic hypothermia. J Neurochem 65:1704-1711.
17. Graham SH, Chen J, Lan J, Leach J, Simon RP (1994): Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channel, BW619C89, in rat middle cerebral artery occlusion. J Pharmacol Exp Ther 269:854-859.
18. Hayes RL, Jenkins LW, Lyeth BG, Balster RL, Robinson SE, Clifton GL, Stubbins JF, Young HF (1988): Pretreatment with phencyclidine, an N-methyl-D-aspartate antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J Neurotrauma 5:259-274.
19. Hebert T, Drapeau L, Pradier L, Dunn RJ (1994): Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 45:1055-1060.
20. Hicks RR, Smith DH, Gennarelli TA, McIntosh TK (1994): Kynurenate is neuroprotective following experimental brain injury in the rat. Brain Res 655:91-96.
21. Hicks RR, Smith DH, Lowenstein DH, Saint Marie RL, McIntosh TK (1993): Mild experimental brain injury in the rat induces cognitive deficits associated with regional neuronal loss in the hippocampus. J Neurotrauma 10:405-414.
22. Hicks RR, Smith DH, McIntosh TK (1995): Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Res 678:151-160.
23. Hicks RR, Soares HD, Smith DH, McIntosh TK (1996): Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat. Acta Neuropathol 91:236-246.
24. Hovda DA, Becker DP, Katayama Y (1992): Secondary injury and acidosis. J Neurotrauma 9:547-560.
25. Katayama Y, Becker DP, Tamura T, Hovda DA (1990): Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg 73:889-900.
26. Lowenstein DH, Thomas MJ, Smith DH, McIntosh TK (1992): Selective vulnerability of dentate hilar neurons following traumatic brain injury: A potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci 12:4846-4853.
27. Malgouris C, Bardot F, Daniel M, Pellis F, Rataud J, Uzan A, Blanchard J-C, Laduron PM (1989): Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J Neurosci 9:3720-3727.
28. Mary V, Wahl F, Stutzmann J-M (1995): Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission. Neurosci Lett 201:92-96.
29. McDermott KL, Raghupathi R, Fernandez SC, Saatman KE, Protter AA, Finkelstein SP, Smith DH, McIntosh TK (1997): Delayed administration of basic fibroblast growth factor attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J Neurotrauma 14:191-200.
30. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI (1996a): Neuropathological sequelae of experimental brain injury: Relationship to neurochemical and biomechanical mechanisms. Lab Invest 74:315-342.
31. McIntosh TK, Smith DH, Voddi M, Perri BR, Stutzmann J-M (1996b): Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J Neurotrauma 13:767-780.
32. McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Faden AI (1989a): Traumatic brain injury in the rat: Characterization of a lateral fluid percussion model. Neuroscience 28:233-244.
33. McIntosh TK, Vink R, Soares HD, Hayes RL, Simon R (1989b): Effect of N-methyl-D-aspartate receptor blocker MK-801 on neurological function after experimental brain injury. J Neurotrauma 6:247-259.
34. Meldrum BS, Swan JH, Leach MJ, Millan MH, Gwinn R, Kadota K, Graham SH, Chen J, Simon RP (1992): Reduction of glutamate release and protection against ischemic brain damage by BW1003C87. Brain Res 593:1-6.
35. Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, Munsat TL, Powe L, Rothstein J, Salzman P, Sufit RL (1996): Clinical trials of riluzole in patients with ALS. Neurology 47:S86-S92.
36. Mizoule J, Meldrum B, Mazadier M, Croucher M, Ollat C, Uzan A, Legrand J-J, Gueremy C, Le Fur G (1985): 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission - I. Anticonvulsant properties. Neuropharmacology 24:767-773.
37. Monaghan DT, Cotman CW (1986): Identification and properties of N-methyl-D-aspartate receptors in rat brain plasma membranes. Proc Natl Acad Sci 83:7532-7536.
38. Nilsson P, Hillered L, Ponten U, Urgerstedt V (1990): Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J Cereb Blood Flow Metab 10:631-637.
39. Okiyama K, Smith DH, Gennarelli TA, Simon RP, Leach M, McIntosh TK (1995): The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J Neurochem 64:802-809.
40. Olney JW (1971): Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J Neuropath Exp Neurol 30:75-90.
41. Olney JW, Ho OL, Rhee V (1971): Cytotoxic effects of acidic and sulphur-containing amino acid on the infant mouse central nervous system. Exp Brain Res 14:61-76.
42. Olney J, Price M, Salles KS, Labruyere J, Frierdich G (1987): MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Eur J Pharmacol 141:357-361.
43. Palmer AM, Marion DW, Botscheller ML, Swedlow PE, Styren SD, DeKosky ST (1993): Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 61:2015-2024.
44. Peluffo H, Estevez A, Barbeito L, Stutzmann J-M (1997): Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyte monolayers. Neurosci Lett 228:1-5.
45. Povlishock JT, Hayes RL, Michel ME, McIntosh TK (1994): Workshop on animal models of traumatic brain injury. J Neurotrauma 11:723-731.
46. Pratt J, Rataud J, Bardot F, Roux M, Blanchard J-C, Laduron PM, Stutzmann J-M (1992): Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia. Neurosci Lett 140:225-230.
47. Rothman SM, Olney JW (1987): Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299-302.
48. Shapira Y, Yadid G, Cotev S, Niska A, Shohami E (1990): Protective effect of MK-801 in experimental brain injury. J Neurotrauma 7:131-139.
49. Siesjö BK (1992): Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 77:169-184.
50. Sinson G, Perri BR, Trojanowski JQ, Flamm ES, McIntosh TK (1997): Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury. J Neurosurg 86:511-518.
51. Sinson G, Voddi M, McIntosh TK (1995): Nerve growth factor administration attenuates cognitive but not neurobehavioral motor dysfunction or hippocampal cell loss following fluidpercussion brain injury in rats. J Neurochem 65:2209-2216.
52. Smith DH, Chen X-H, Pierce JES, Wolf JA, Trojanowski JQ, Graham DI, McIntosh TK (1997a): Progressive atrophy and neuronal death for one year following brain trauma in the rat. J Neurotrauma 14:715-727.
53. Smith DH, Okiyama K, Thomas MJ, Claussen B, McIntosh TK (1991): Evaluation of memory dysfunction following experimental brain injury using the Morris Water Maze. J Neurotrauma 8:259-269.
54. Smith DH, Okiyama K, Thomas MJ, McIntosh TK (1993): Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J Neurosci 13: 5383-5392.
55. Smith DH, Perri BR, Raghupathi R, Saatman KE, McIntosh TK (1997b): Remacemide hydrochloride reduces cortical lesion volume following brain trauma in the rat. Neurosci Lett 231:135-138.
56. Soares HD, Hicks RR, Smith DH, McIntosh TK (1995a): Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15:8223-8233.
57. Soares HD, Sinson G, McIntosh TK (1995b): Fetal hippocampal transplants attenuate hippocampal CA3 pyramidal cell death resulting from fluid percussion brain injury in the rat. J Neurotrauma 12:1059-1067.
58. Soares HD, Thomas M, Cloherty K, McIntosh TK (1992): Development of prolonged focal cerebral edema and regional cation change following experimental brain injury in the rat. J Neurochem 58:1845-1852.
59. Stutzmann J-M, Bohme GA, Gandolfo G, Gottesmann C, Lafforgue J, Blanchard J-C, Laduron PM, Lazdunski M (1991): Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat. Eur J Pharmacol 193:223-229.
60. Stutzmann J-M, Doble A (1995): Blockade of glutaminergic transmission and neuroprotection: the strange case of riluzole. In Jolles G, Stutzmann J-M (eds): "Neurodegenerative Disease." Academic Press, pp 205-214.
61. Stutzmann J-M, Pratt J, Boraud T, Gross C (1996): Riluzole's effect on post-traumatic spinal cord injury in the rat. NeuroReport 7:387-392.
62. Sun F-Y, Faden AI (1995): Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injury. Brain Res 673:133-140.
63. Wahl F, Allix M, Plotkine M, Boulu RG (1993): Effect of riluzole on focal cerebral ischemia in rats. Eur J Pharmacol 230:209-214.
64. Wahl F, Renou E, Mary V, Stutzmann J-M (1997): Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury. Brain Res 756:247-255.
65. Yamakami I. McIntosh TK (1991): Alterations in regional cerebral blood flow following brain injury in the rat. J Cereb Blood Flow Metab 11:655-660.